Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07115446) titled 'Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer' on Aug. 4.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Hansoh BioMedical R&D Company

Condition: Advanced Prostate Cancer

Intervention: Drug: HS-20093

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: August 2025

Target Sample Size: 63

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07115446

Published by HT Digital Content Services with permission from Health...